Regeneron Pharmaceuticals

REGN

NASDAQ·Health Care

Market Cap
-
P/E Ratio
-
Dividend Yield
-

Company Overview

Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap.

Industry
Biotechnology

Financial Summary

Revenue (TTM)
$4.10B
Net Income (TTM)
$4.34B
Total Assets
$33.08B
Total Debt
$1.98B
Total Equity
$18.77B
Market Cap
-

Valuation Metrics

P/E Ratio
-
P/B Ratio
-
Profit Margin
105.72%
ROE
23.11%
ROA
13.11%
Dividend Yield
-